Form 4: Fulgent Genetics CFO Paul Kim Reports Routine Stock Disposition for Tax Obligations

Fulgent Genetics CFO and Treasurer Paul Kim reported the disposition of 1,131 shares of common stock on June 1, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Paul Kim, the Chief Financial Officer and Treasurer of Fulgent Genetics, Inc. (FLGT), reported a transaction on June 1, 2025.
• The transaction involved the disposition of 1,131 shares of Fulgent Genetics common stock at a price of $20.72 per share.
• This disposition was categorized as a 'tax withholding' transaction (Code F), meaning the shares were withheld by the company to satisfy tax obligations.
• The tax obligations arose from the vesting of restricted stock units (RSUs) that were originally granted to Mr. Kim on February 28, 2022.
• Following this reported transaction, Mr. Kim beneficially owns 342,571 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to RSU vesting and does not indicate a change in management's outlook or company performance, thus having a neutral sentiment.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes, which is a common and expected event across all industries when restricted stock units or similar equity awards vest for executives. It does not provide insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• This routine tax-related transaction has minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as it is a standard part of executive compensation and tax compliance.

Key Dates

Recommendation

Keywords

Fulgent Genetics, FLGT, Paul Kim, CFO, Treasurer, Form 4, insider transaction, stock disposition, restricted stock units, RSU vesting, tax withholding